title: Asymmetric aneuploidy in mesenchymal stromal cells detected by in situ karyotyping and fluorescence in situ hybridization: suggestions for reference values for stem cells.
abstract: Cytogenetic testing is important to ensure patient safety before therapeutic application of mesenchymal stromal cells (MSCs). However, the standardized methods and criteria for the screening of chromosomal abnormalities of MSCs have not yet been determined. We investigated the frequency of cytogenetic aberrations in MSCs using G-banding and fluorescence in situ hybridization (FISH) and suggest reference values for aneuploidy in MSCs. Cytogenetic analysis was performed on 103 consecutive cultures from 68 MSCs (25 adipose-origin, 20 bone marrow-origin, 18 cord blood-origin, and 5 neural stem cells; 8 from adipose tissue of patients with breast cancer and 60 from healthy donors). We compared the MSC aneuploidy patterns with those of hematological malignancies and benign hematological diseases. Interphase FISH showed variable aneuploid clone proportions (1%-20%) in 68 MSCs. The aneuploidy patterns were asymmetric, and aneuploidy of chromosomes 16, 17, 18, and X occurred most frequently. Clones with polysomy were significantly more abundant than those with monosomy. The cutoff value of maximum polysomy rates (upper 95th percentile value) was 13.0%. By G-banding, 5 of the 61 MSCs presented clonal chromosomal aberrations. Aneuploidy was asymmetric in the malignant hematological diseases, while it was symmetric in the benign hematological diseases. We suggest an aneuploidy cutoff value of 13%, and FISH for aneuploidy of chromosomes 16, 17, 18, and X would be informative to evaluate the genetic stability of MSCs. Although it is unclear whether the aneuploid clones might represent the senescent cell population or transformed cells, more attention should be focused on the safety of MSCs, and G-banding combined with FISH should be performed.
authors.affiliation: 1 Department of Laboratory Medicine, Seoul National University College of Medicine , Seoul, Republic of Korea.
authors.forename: Seon Young
authors.initials: SY
authors.lastname: Kim
authors.forename: Kyongok
authors.initials: K
authors.lastname: Im
authors.forename: Si Nae
authors.initials: SN
authors.lastname: Park
authors.forename: Jiseok
authors.initials: J
authors.lastname: Kwon
authors.forename: Jung-Ah
authors.initials: JA
authors.lastname: Kim
authors.forename: Qute
authors.initials: Q
authors.lastname: Choi
authors.forename: Sang Mee
authors.initials: SM
authors.lastname: Hwang
authors.forename: Sung-Hee
authors.initials: SH
authors.lastname: Han
authors.forename: Sunghoon
authors.initials: S
authors.lastname: Kwon
authors.forename: Il-Hoan
authors.initials: IH
authors.lastname: Oh
authors.forename: Dong Soon
authors.initials: DS
authors.lastname: Lee
mesh_terms: D000782:Aneuploidy; D002871:Chromosome Banding; D019337:Hematologic Neoplasms / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D059630:Mesenchymal Stem Cells / Q000378:metabolism / Q000473:pathology*